Hyundai ADM Bio Balance Sheet Health
Financial Health criteria checks 4/6
Hyundai ADM Bio has a total shareholder equity of ₩12.8B and total debt of ₩7.5B, which brings its debt-to-equity ratio to 58.2%. Its total assets and total liabilities are ₩43.9B and ₩31.0B respectively.
Key information
58.2%
Debt to equity ratio
₩7.48b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩20.51b |
| Equity | ₩12.84b |
| Total liabilities | ₩31.03b |
| Total assets | ₩43.87b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: A187660's short term assets (₩25.8B) do not cover its short term liabilities (₩29.2B).
Long Term Liabilities: A187660's short term assets (₩25.8B) exceed its long term liabilities (₩1.8B).
Debt to Equity History and Analysis
Debt Level: A187660 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if A187660's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A187660 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: A187660 has sufficient cash runway for 2.5 years if free cash flow continues to reduce at historical rates of 84% each year.